Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $77.6 million versus the consensus estimate of $45.75 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.